Published: 2018-01-24

A study of urinary Bisphenol A levels in endocrine disorders

Anupam Kumar, Rajesh Verma, N. K. Agrawal


Background: Bisphenol A (BPA) is a very common endocrine disruptor. Traditionally high doses of BPA showed adverse effects with respect to organ failure and cancer. However, evidence now shows that doses well below the traditional toxicological threshold have metabolic effects. This observational study was aimed to measure the urinary levels of BPA among patients with endocrine disorders namely type 2 diabetes mellitus, hypothyroidism, non-obstructive azoospermia, polycystic ovarian syndrome (PCOS) and simple obesity, and to correlate urinary BPA levels with different clinical, biochemical and hormonal parameters.

Methods: 30 newly diagnosed cases each of Type 2 diabetes mellitus, primary hypothyroidism, polycystic ovarian syndrome (PCOS), non-obstructive azoospermia and simple obesity were selected for study (single disorder in one patient). Age and sex matched healthy relatives of patients (n=30) were recruited as controls. All cases and controls were subjected to spot urinary BPA level estimation.

Results: There were significant differences obtained in the median values of BPA in urine between cases of azoospermia, and simple obesity as compared to controls whereas no correlation was obtained between urinary BPA levels and BMI or waist hip ratio, in patients of type 2 DM and primary hypothyroidism. Urinary BPA was significantly lower than controls in cases of PCOS.

Conclusions: Urinary levels of BPA are an indicator of its toxic effects especially in patients of non-obstructive azoospermia and simple obesity. The values of BPA in urine were widely distributed showing variability of exposure from the environment. 


Bisphenol A (BPA), Hypothyroidism, Non-obstructive azoospermia, PCOS, Simple obesity, Type 2 diabetes mellitus

Full Text:



Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL 2008 Exposure of the US population to bisphenol A and 4-tertiary-octylphenol:2003-2004. Environ Health Perspect. 2008;116:39-44.

Dickerson SM, Gore AC. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle. Rev Endocr Metab Disord. 2007;8:143-59.

Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24:139-77.

Wise LA, Palmer JR, Rowlings K, Kaufman RH, Herbst AL, Noller KL, et al. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005;105:167-73.

Baird DD, Newbold R. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol. 2005;20:81-4.

Saal VFS, Akingbemi BT, Belcher SM. Chapel Hill Bisphenol an expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol. 2007;24:131-8.

Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect. 2008;16:1642-7

Wang T, Ning G, Bi Y, Xu M, Xu Y, Huang Y, et al. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults. Ann Intern Med. 2012;155:368-74.

Langer P. Persistent organochlorinated pollutants (PCB, DDE, HCB, dioxins, furans) and the thyroid-review 2008. Endocr Regul. 2008;42:79-104.

Ning G, Wang T, Li M, Chen B, XuY, Huang Y, et al. Urinary Bisphenol A concentration associates with obesity and insulin resistance. J Clin Endocrinol Metabol. 2011;97:223-7.

Kandaraki E, Chatzigeorgiou A, Livadas S, Palioura E, Economou F, Koutsilieris M, et al. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab 96:E480-4.